VAsopressin LOading for Refractory septic shock VALOR study

VAsopressin LOading for Refractory septic shock VALOR study - VALOR study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044041

Enrollment

100

Registered

2021-04-26

Start date

2021-04-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.age>=18 2.septic shock (Sepsis-3) 3.require vasopressin administration in the patients given continuous noradrenaline>=0.2gamma 4.not given continuous steroid therapy 5.arterial line inserted 6.informed consent

Exclusion criteria

Exclusion criteria: End of life/Terminal care

Design outcomes

Primary

Measure	Time frame
The catecholamine index change six hours after the initiation of continuous vasopressin administration	—

Countries

Japan

Contacts

Public ContactKensuke Nakamura

Hitachi General Hospital Emergency and Critical Care Medicine

mamashockpapashock@yahoo.co.jp0294-23-1111

Outcome results